DH - Buy Definitive Healthcare Stock On Weakness Analyst Says As Revised Outlook Appears Achievable | Benzinga
Tuesday, Definitive Healthcare Corp (NASDAQ:DH) reported first-quarter adjusted EPS of $0.08, up from $0.06 a year ago, in line with the consensus.
The company reported sales of $63.48 million, up 7%, missing the consensus of $63.99 million.
Adjusted EBITDA was $20 million, or 32% of revenue, compared to $15.7 million, or 26% of revenue in Q1 2023.
In the first quarter, Definitive Healthcare grew its enterprise customer base by 30 or 6% Y/Y, ending with 559 enterprise customers.
Guidance: Definitive Healthcare sees second-quarter revenues of $62M– $63.5M versus a consensus of $65.19 million.
The company forecasts second-quarter adjusted EPS of $0.08–$0.09 versus a consensus of $0.09.
Definitive Healthcare sees fiscal year 2024 ...